BRIEF published on 11/12/2024 at 16:34, 8 days 21 hours ago Metro Bank Appoints New CFO CFO Regulatory Approval Marc Page Metro Bank Executive Appointment
PRESS RELEASE published on 11/12/2024 at 16:29, 8 days 21 hours ago Board Update Metro Bank Holdings PLC appoints Marc Page as Executive Director and Chief Financial Officer following regulatory approval on 12 November 2024. Board update in line with LR 6.4.6(4) Chief Financial Officer Metro Bank Holdings PLC Executive Director Marc Page LR 6.4.6(4)
BRIEF published on 11/12/2024 at 08:10, 9 days 5 hours ago Metro Bank Reports Positive Q3 2024 Performance Profitability Strategic Shift Q3 2024 Metro Bank Financial Update
PRESS RELEASE published on 11/12/2024 at 08:05, 9 days 5 hours ago Third Quarter 2024 Trading Update Metro Bank Holdings PLC releases positive third-quarter trading update for 2024, with improved profits and NIM. Continues strategic balance sheet repositioning and collaboration with Infosys Trading Update Balance Sheet Metro Bank Profits MTRO
BRIEF published on 11/12/2024 at 08:05, 9 days 5 hours ago Metro Bank Resolves FCA Enquiries with £16.7 Million Penalty Profitability Strategic Growth Metro Bank FCA Penalty Transaction Monitoring
PRESS RELEASE published on 11/12/2024 at 08:00, 9 days 5 hours ago Conclusion of FCA enquiries Metro Bank Holdings PLC resolves FCA enquiries with £16.7 million penalty for transaction monitoring system deficiencies. CEO emphasizes focus on future growth and profitability Strategic Priorities Metro Bank FCA Enquiries Financial Penalty Growth Agenda
BRIEF published on 11/01/2024 at 16:05, 19 days 21 hours ago Metro Bank Holdings PLC Announces Total Voting Rights Shareholders Total Voting Rights Disclosure Rules Metro Bank FCA Compliance
PRESS RELEASE published on 11/01/2024 at 16:00, 19 days 21 hours ago Total Voting Rights Metro Bank Holdings PLC released an update on its total voting rights as of 01 November 2024, with 672,862,832 ordinary shares in issue. Shareholders can use this figure for transparency rule calculations Shareholders Financial Disclosure Total Voting Rights Transparency Rules Metro Bank
BRIEF published on 10/11/2024 at 16:05, 1 month 9 days ago Metro Bank Announces Board Changes Board Changes Non-Executive Director Metro Bank CFO Transition Shareholder Nomination
PRESS RELEASE published on 10/11/2024 at 16:00, 1 month 9 days ago Board Update Metro Bank Holdings PLC announces board update: Cristina Alba Ochoa steps down as CFO and is appointed as Non-Executive Director. Marc Page joins as CFO pending regulatory approval Regulatory Approval Metro Bank Holdings PLC Marc Page Cristina Alba Ochoa Board Update
Published on 11/21/2024 at 13:30, 20 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 20 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 50 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 50 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 50 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 15 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 35 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 52 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 30 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 5 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 5 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
